Page 1 | Search Results | Diabetes | American Diabetes Association

1-20 of 26

Sort by

Sort Order Select

Meeting Abstracts

1702-P: High Circulating MIF Levels Indicate the Association with Atypical Antipsychotic-Induced Metabolic Adverse Effects

XI CHEN, PINGYI GAO, YADAN QI, DONGHONG CUI, DAKE QI

Diabetes 2024;73(Supplement_1):1702-P

https://doi.org/10.2337/db24-1702-P

Published: 14 June 2024

View article titled, 1702-P: High Circulating MIF Levels Indicate the Association with Atypical Antipsychotic-Induced Metabolic Adverse Effects

Journal Articles

Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects

Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A. DeFronzo

Diabetes 2024;73(6):896–902

https://doi.org/10.2337/db23-0457

Published: 21 March 2024

View article titled, Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects

Meeting Abstracts

869-P: Effect of Dapagliflozin on Renal Oxygen Delivery and Consumption in T2DM and NGT Subjects

DEVJIT TRIPATHY, XI CHEN, ROBERT CHILTON, ANDREA A. HANSIS-DIARTE, MARZIEH SALEHI, CAROLINA SOLIS-HERRERA, EUGENIO CERSOSIMO, RALPH A. DEFRONZO

Diabetes 2023;72(Supplement_1):869-P

https://doi.org/10.2337/db23-869-P

Published: 20 June 2023

View article titled, 869-P: Effect of Dapagliflozin on Renal Oxygen Delivery and Consumption in T2DM and NGT Subjects

Meeting Abstracts

1578-P: Hyaluronidase-1 Inhibits Hepatic Gluconeogenesis

XI CHEN, YI ZHU

Diabetes 2023;72(Supplement_1):1578-P

https://doi.org/10.2337/db23-1578-P

Published: 20 June 2023

View article titled, 1578-P: Hyaluronidase-1 Inhibits Hepatic Gluconeogenesis

Meeting Abstracts

895-P: Effect of Long-Term Empagliflozin Therapy on Plasma Beta-Hydroxy Butyrate (ß-OHB)—Lack of Effect of Concomitant Insulin, GLP-1 Agonist, or Pioglitazone Therapy

LUIS C. ORTIZ, JOY WORTHAM, SHEILA PINKSON, JONATHAN TREJO, AMIEL S. MENDOZA, XI CHEN, DEVJIT TRIPATHY

Diabetes 2023;72(Supplement_1):895-P

https://doi.org/10.2337/db23-895-P

Published: 20 June 2023

View article titled, 895-P: Effect of Long-Term Empagliflozin Therapy on Plasma Beta-Hydroxy Butyrate (ß-OHB)—Lack of Effect of Concomitant Insulin, GLP-1 Agonist, or Pioglitazone Therapy

Meeting Abstracts

1598-P: MIF-upregulated CD74 in Liver Contributes to the Development of NAFLD

LIUJUN CHEN, LISHA LI, YIHENG HUANG, XI CHEN, YADAN QI, HAIBIN TONG, HONG WU, DAKE QI

Diabetes 2023;72(Supplement_1):1598-P

https://doi.org/10.2337/db23-1598-P

Published: 20 June 2023

View article titled, 1598-P: MIF-upregulated CD74 in Liver Contributes to the Development of NAFLD

Meeting Abstracts

1615-P: The Peripheral and Central Cross Talk Mediated by Adipose MIF—A Novel Mechanism of Hyperphagia following Olanzapine Treatment

XI CHEN, YIHENG HUANG, YADAN QI, LIUJUN CHEN, LISHA LI, PINGYI GAO, DONGHONG CUI, DAKE QI

Diabetes 2023;72(Supplement_1):1615-P

https://doi.org/10.2337/db23-1615-P

Published: 20 June 2023

View article titled, 1615-P: The Peripheral and Central Cross Talk Mediated by Adipose MIF—A Novel Mechanism of Hyperphagia following Olanzapine Treatment

Meeting Abstracts

6-OR: PAR2 Downregulates Adipose LPL through MIF—A Novel Adipose Mechanism Contributing to the Development of Hypertriglyceridemia

YIHENG HUANG, LISHA LI, LIUJUN CHEN, XI CHEN, PINGYI GAO, YADAN QI, DAKE QI

Diabetes 2023;72(Supplement_1):6-OR

https://doi.org/10.2337/db23-6-OR

Published: 20 June 2023

View article titled, 6-OR: PAR2 Downregulates Adipose LPL through MIF—A Novel Adipose Mechanism Contributing to the Development of Hypertriglyceridemia

Meeting Abstracts

55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects

XI CHEN, CAROLINA SOLIS-HERRERA, DEVJIT TRIPATHY, ANDREA A. HANSIS-DIARTE, ROBERT CHILTON, EUGENIO CERSOSIMO, RALPH A. DEFRONZO

Diabetes 2022;71(Supplement_1):55-LB

https://doi.org/10.2337/db22-55-LB

Published: 01 June 2022

View article titled, 55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects

Meeting Abstracts

360-OR: Hyperglucagonemia Reduces De Novo Lipogenesis and Increases Gluconeogenesis in Healthy Subjects

XI CHEN, FABRIZIA CARLI, SAMANTHA PEZZICA, GABRIELE MOCCIARO, DEMETRIO CIOCIARO, AMALIA GASTALDELLI, RALPH A. DEFRONZO, DEVJIT TRIPATHY

Diabetes 2022;71(Supplement_1):360-OR

https://doi.org/10.2337/db22-360-OR

Published: 01 June 2022

View article titled, 360-OR: Hyperglucagonemia Reduces De Novo Lipogenesis and Increases Gluconeogenesis in Healthy Subjects

Meeting Abstracts

257-OR: Short-Term Hyperglucagonemia Induces Adipose Tissue Insulin Resistance and Inflammation In Vivo

XI CHEN, MARCEL FOURCAUDOT, LUKE NORTON, RALPH A. DEFRONZO, DEVJIT TRIPATHY

Diabetes 2021;70(Supplement_1):257-OR

https://doi.org/10.2337/db21-257-OR

Published: 01 June 2021

View article titled, 257-OR: Short-Term Hyperglucagonemia Induces Adipose Tissue Insulin Resistance and Inflammation In Vivo

Journal Articles

Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects

Aurora Merovci, Devjit Tripathy, Xi Chen, Ivan Valdez, Muhammad Abdul-Ghani, Carolina Solis-Herrera, Amalia Gastaldelli, Ralph A. DeFronzo

Diabetes 2021;70(1):204–213

https://doi.org/10.2337/db20-0039

Published: 08 October 2020

View article titled, Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects

Meeting Abstracts

1914-P: Prolonged (12-Hour) Glucagon Infusion Stimulates Adipocyte Lipolysis and Inflammation In Vivo in Humans

DEVJIT TRIPATHY, MARCEL FOURCAUDOT, LUKE NORTON, RALPH A. DEFRONZO, XI CHEN

Diabetes 2020;69(Supplement_1):1914-P

https://doi.org/10.2337/db20-1914-P

Published: 01 June 2020

View article titled, 1914-P: Prolonged (12-Hour) Glucagon Infusion Stimulates Adipocyte Lipolysis and Inflammation In Vivo in Humans

Meeting Abstracts

1707-P: Differential Effect of Prolonged Glucagon Infusion on Plasma Lipidome in Humans

XI CHEN, XIANLIN HAN, JONATHAN TREJO, EMINA CASE, RALPH A. DEFRONZO, DEVJIT TRIPATHY

Diabetes 2020;69(Supplement_1):1707-P

https://doi.org/10.2337/db20-1707-P

Published: 01 June 2020

View article titled, 1707-P: Differential Effect of Prolonged Glucagon Infusion on Plasma Lipidome in Humans

Meeting Abstracts

1465-P: Application of the New Cluster-Based Classification of Adult-Onset Diabetes in a South Texas Veteran Population, Increased Incidence of Diabetic Nephropathy in Veterans with Severe Insulin Resistance

JONATHAN TREJO, SHEILA PINKSON, LYAN GONDIN, LUCY ESTEVE, XI CHEN, DEVJIT TRIPATHY

Diabetes 2020;69(Supplement_1):1465-P

https://doi.org/10.2337/db20-1465-P

Published: 01 June 2020

View article titled, 1465-P: Application of the New Cluster-Based Classification of Adult-Onset Diabetes in a South Texas Veteran Population, Increased Incidence of Diabetic Nephropathy in Veterans with Severe Insulin Resistance

Meeting Abstracts

274-OR: Beta-Cell Dysfunction Is Associated with Impaired Insulin-Mediated Suppression of Glucagon in Obese Hispanic Americans

XI CHEN, ENRIQUE R. MALDONADO CORCHADO, AURORA MEROVCI, EMINA CASE, DEVJIT TRIPATHY, RALPH A. DEFRONZO

Diabetes 2019;68(Supplement_1):274-OR

https://doi.org/10.2337/db19-274-OR

Published: 01 June 2019

View article titled, 274-OR: Beta-Cell Dysfunction Is Associated with Impaired Insulin-Mediated Suppression of Glucagon in Obese Hispanic Americans

Meeting Abstracts

1951-P: Prolonged (12-Hour) Glucagon Infusion Leads to Transient Elevation of Plasma Glucose but Sustained Elevation of Hepatic Glucose Production

XI CHEN, AURORA MEROVCI, EMINA CASE, RALPH A. DEFRONZO, DEVJIT TRIPATHY

Diabetes 2019;68(Supplement_1):1951-P

https://doi.org/10.2337/db19-1951-P

Published: 01 June 2019

View article titled, 1951-P: Prolonged (12-Hour) Glucagon Infusion Leads to Transient Elevation of Plasma Glucose but Sustained Elevation of Hepatic Glucose Production

Meeting Abstracts

1967-P: Mild Physiologic Hyperglycemia Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects

AURORA MEROVCI, XI CHEN, RALPH A. DEFRONZO, DEVJIT TRIPATHY

Diabetes 2019;68(Supplement_1):1967-P

https://doi.org/10.2337/db19-1967-P

Published: 01 June 2019

View article titled, 1967-P: Mild Physiologic Hyperglycemia Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects

Journal Articles

miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity

Eun-Hee Koh, Natasha Chernis, Pradip K. Saha, Liuling Xiao, David A. Bader, Bokai Zhu, Kimal Rajapakshe, Mark P. Hamilton, Xia Liu, Dimuthu Perera, Xi Chen, Brian York, Michael Trauner, Cristian Coarfa, Mandeep Bajaj, David D. Moore, Tuo Deng, Sean E. McGuire, Sean M. Hartig

Diabetes 2018;67(12):2541–2553

https://doi.org/10.2337/db17-1378

Published: 12 July 2018

View article titled, miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity

Includes: Supplementary data

Meeting Abstracts

Circulating ANGPTL8 and ANGPTL4 Levels Are Increased in Patients with Hyperglycemia Combined Dyslipidemia

XUEFENG YU, PUHAN LU, XI CHEN

Diabetes 2018;67(Supplement_1):333-OR

https://doi.org/10.2337/db18-333-OR

Published: 01 July 2018

View article titled, Circulating ANGPTL8 and ANGPTL4 Levels Are Increased in Patients with Hyperglycemia Combined Dyslipidemia

NARROW

1702-P: High Circulating MIF Levels Indicate the Association with Atypical Antipsychotic-Induced Metabolic Adverse Effects

Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects

869-P: Effect of Dapagliflozin on Renal Oxygen Delivery and Consumption in T2DM and NGT Subjects

1578-P: Hyaluronidase-1 Inhibits Hepatic Gluconeogenesis

895-P: Effect of Long-Term Empagliflozin Therapy on Plasma Beta-Hydroxy Butyrate (ß-OHB)—Lack of Effect of Concomitant Insulin, GLP-1 Agonist, or Pioglitazone Therapy

1598-P: MIF-upregulated CD74 in Liver Contributes to the Development of NAFLD

1615-P: The Peripheral and Central Cross Talk Mediated by Adipose MIF—A Novel Mechanism of Hyperphagia following Olanzapine Treatment

6-OR: PAR2 Downregulates Adipose LPL through MIF—A Novel Adipose Mechanism Contributing to the Development of Hypertriglyceridemia

55-LB: Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2DM and NGT Subjects

360-OR: Hyperglucagonemia Reduces De Novo Lipogenesis and Increases Gluconeogenesis in Healthy Subjects

257-OR: Short-Term Hyperglucagonemia Induces Adipose Tissue Insulin Resistance and Inflammation In Vivo

Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects

1914-P: Prolonged (12-Hour) Glucagon Infusion Stimulates Adipocyte Lipolysis and Inflammation In Vivo in Humans

1707-P: Differential Effect of Prolonged Glucagon Infusion on Plasma Lipidome in Humans

1465-P: Application of the New Cluster-Based Classification of Adult-Onset Diabetes in a South Texas Veteran Population, Increased Incidence of Diabetic Nephropathy in Veterans with Severe Insulin Resistance

274-OR: Beta-Cell Dysfunction Is Associated with Impaired Insulin-Mediated Suppression of Glucagon in Obese Hispanic Americans

1951-P: Prolonged (12-Hour) Glucagon Infusion Leads to Transient Elevation of Plasma Glucose but Sustained Elevation of Hepatic Glucose Production

1967-P: Mild Physiologic Hyperglycemia Impairs Insulin-Mediated Suppression of Plasma Glucagon in Healthy Normal Glucose Tolerant Subjects

miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in Obesity

Circulating ANGPTL8 and ANGPTL4 Levels Are Increased in Patients with Hyperglycemia Combined Dyslipidemia

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only